Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-03 Sale |
2024-06-05 7:25 pm |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
1,500,000 | $54.75 | $82,125,000 | 3,344,601 (Indirect Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 7:23 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer |
822,721 | $54.75 | $45,043,975 | 3,515,007 (Indirect Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 7:19 pm |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures I LP Avalon BioVentures SPV I L.P. 10% Owner |
1,500,000 | $54.75 | $82,125,000 | 6,611,234 (Indirect Direct) |
View |
| 2023-11-13 Purchase |
2023-11-15 4:48 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
849,854 | $5.87 | $4,988,643 | 5,329,346 (Indirect) |
View |
| 2023-11-13 Purchase |
2023-11-15 4:46 pm |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect) |
View |
| 2023-11-13 Purchase |
2023-11-13 7:11 pm |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner |
849,854 | $5.87 | $4,988,643 | 9,716,563 (Indirect Direct) |
View |
| 2023-07-19 Purchase |
2023-07-21 4:31 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-28 4:30 pm |
N/A 2034-06-25 |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
10,850 | $0 | 118,878 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:30 pm |
N/A 2034-06-25 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
10,850 | $0 | 10,850 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:30 pm |
N/A 2034-06-25 |
Janux Therapeutics Inc. | JANX | Simson Jake Director |
10,850 | $0 | 10,850 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 4:30 pm |
N/A 2034-06-25 |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
10,850 | $0 | 76,393 (Direct) |
View |
| 2024-02-29 Other |
2024-03-04 7:31 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Avalon Ventures XI L.P. Avalon BioVentures SPV I L.P. Avalon BioVentures I LP 10% Owner |
1,016,200 | $0 | 5,009,239 (Direct) |
View |
| 2024-02-29 Other |
2024-03-04 4:44 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
2,986 | $0 | 111,014 (Direct) |
View |
| 2024-02-29 Other |
2024-03-04 4:33 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
1,493 | $0 | 67,036 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:54 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer |
111,000 | $0 | 111,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:53 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer |
151,500 | $0 | 151,500 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:52 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
157,000 | $0 | 157,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:50 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:49 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO |
356,500 | $0 | 356,500 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-03 4:47 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer |
147,000 | $0 | 147,000 (Direct) |
View |
Ownership |
2024-01-03 4:45 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer |
0 | $0 | 746,332 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:15 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:10 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:09 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | McNulty Alana B. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:08 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Simson Jake Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:08 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Kung Winston Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:07 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:06 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:06 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:36 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:35 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:34 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:33 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:32 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Godfrey Wayne Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:30 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
310,000 | $0 | 310,000 (Direct) |
View |
Ownership |
2023-01-05 4:29 pm |
N/A 2031-03-09 |
Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer |
0 | $0 | 217,629 (Direct) |
View |
| 2022-09-21 Option Award |
2022-09-22 6:00 pm |
N/A 2032-09-20 |
Janux Therapeutics Inc. | JANX | Kung Winston Director |
39,375 | $0 | 39,375 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:39 pm |
N/A 2032-06-13 |
Janux Therapeutics Inc. | JANX | Barrett Ronald W Director |
12,500 | $0 | 12,500 (Direct) |
View |